Statistical Science


Dr Gianluca Baio awarded funds to conduct research on the health economic and societal impact of Pembrolizumab in the treatment of melanoma

24 March 2017

Dr Gianluca Baio has been awarded an unrestricted research grant sponsored by Merck Sharpe and Dohme to investigate the health economic performance and the societal impact of Pembrolizumab, a treatment for melanoma that has spread or can't be removed with surgery and non small cell lung cancer that has spread and the cancer cells have proteins called PD-L1. The research will investigate the potential expansion to other indications and the impact on public funding as well clinical benefits.